Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer : a multicentre, randomised, open-label, phase 2, crossover trial

DJ Khalaf, CK Kollmannsberger, BJ Eigl, K Noonan, D Wadhwa, A Attwell, B Keith, SL Ellard, L Le, ME Gleave, AW Wyatt, M Annala, KN Chi, S Taavitsainen, DL Finch, C Oja, J Vergidis, M Zulfiqar, K Sunderland, AA Azad

Research output: Contribution to journalArticleScientificpeer-review

80 Citations (Scopus)
Original languageEnglish
Pages (from-to)p1730-1739
JournalThe Lancet Oncology
Issue number12
Publication statusPublished - 2019
Publication typeA1 Journal article-refereed

Publication forum classification

  • Publication forum level 3

Cite this